Publication
Article
BioPharm International
BioPharm International-06-15-2015Volume2015 eBook Issue 1
Taking a “Development-by-Design” Approach to Cell Therapies
Author(s):
Whether outsourcing or developing cell therapies in-house, success demands a focus on quality, cost of goods, and sustainability from the start.
Cell therapies, both autologous and allogeneic, have come a long way in just a few years. Failures, often in clinical stages, have been traced to problems with manufacturing and failure to understand process requirements earlier in the development process.
Download
BioPharm International’s 2015 Outsourcing Resources eBook.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Videos
Related Content
